Hoffmann-La Roche Inc. filed patent application US20260092073A1 for novel heterocyclic compounds having general formula I, covering compositions containing these compounds and methods of using them. The application was published April 2, 2026 with filing date October 15, 2025. Nine inventors are named including David BON, Lea Aurelie BOUCHE, and Wolfgang GUBA. CPC Classification C07D 498/04 indicates fused heterocyclic systems with bridgehead nitrogen atoms.\n\nPharmaceutical companies and drug manufacturers should review the patent claims to assess freedom-to-operate for any heterocyclic compound development programs. While patent applications do not create immediate compliance obligations, monitoring issued patents from competitors is essential for R&D planning. No deadlines or penalties apply to this publication.